382
panel
The ESG Pay-off: Aligning Profitability, Performance, and Impact
Environmental, social, and governance issues are top of mind for institutional investors and the
ir public constituents alike by now.
+ Read More
panel
Innovations to Build Food Resiliency
Today's global food systems present numerous, significant opportunities for innovative restructu
ring that would reduce waste, environmental degradation, and global hunger.
+ Read More
panel
Rethinking Health Care in the Post-Pandemic Era
While the global coronavirus pandemic highlighted numerous shortcomings of current health care s
ystems, it helped accelerate the implementation of new systems and innovative health-tech solutions to address needs.
+ Read More
panel
Speaker and Sponsor Reception | Celebrating Singapore (Invite only)
Admission is by invitation only.
panel
Our Shared Responsibility: Advancing Green Financing (Invite only)
This discussion brings together leading investors, progressive regulators, and other senior exec
utives in the ESG-linked investment space to discuss the biggest problems in sustainable finance.
+ Read More
panel
The Long and Short of Patient Capital
Ever-changing short-term market conditions and compounded uncertainty over the long term have re
quired asset owners to deploy increasingly innovative fund-management strategies.
+ Read More
panel
Asset Management: Are We at an Inflection Point?
The COVID-19 pandemic and rising global conflict have affected the economy, investment strategie
s, regulatory environment, and, consequently, client value sentiments.
+ Read More
panel
ESG in the Asia-Pacific and Why it Matters (Invite only)
Assessing environmental, social and governance (ESG) risk factors in Asia Pacific (APAC) markets
has been an important component in mobilizing the allocation of capital towards sustainable finance opportunities.
+ Read More
panel
Financial Innovations Lab—Best Practices of Sovereign Wealth Funds: The Case for the Philippines (Invite only)
Over the years, the Philippines has considered creating a sovereign wealth fund (SWF) and has ta
ken steps to study the potential merits and feasibility of establishing a SWF.
+ Read More
article
Comments on Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products, Federal Register Docket FDA-2016-D-3561
Lauren K. Roth
Associate Commissioner for Policy
Food and Drug Administration
5630 Fishers Lane, Rm.
1061
Rockville, MD 20852
Dear Ms. Roth,
+ Read More
article
Tambourine Philanthropies Commits Over $5 Million in New Funding for Research into ALS, in Partnership with the Milken Institute
WASHINGTON, DC (April 30, 2024) — Tambourine Philanthropies (Tambourine), in partnership w
ith the Milken Institute Science
+ Read More
article
Tambourine Philanthropies’ ALS Breakthrough Research Fund Awardees
Tambourine Philanthropies and the Milken Institute Science Philanthropy Accelerator for Research and
Collaboration (SPARC), are pleased to announc
+ Read More